GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » YoY EBITDA Growth

Etropal AD (XBUL:ETR) YoY EBITDA Growth : 100.00% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Etropal AD YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Etropal AD's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 100.00%.

Etropal AD's EBITDA per Share for the three months ended in Dec. 2023 was лв0.00.

Etropal AD YoY EBITDA Growth Historical Data

The historical data trend for Etropal AD's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Etropal AD YoY EBITDA Growth Chart

Etropal AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.00 -6.55 -443.95 114.07 193.42

Etropal AD Quarterly Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -192.06 113.64 112.29 116.89 100.00

Etropal AD YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Etropal AD's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.223-0.076)/ | 0.076 |
=193.42 %

Etropal AD's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Mar. 2022 )) / | EBITDA per Share (Q: Mar. 2022 )) |
=(0--0.058)/ | -0.058 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Etropal AD YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Etropal AD's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Etropal AD Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Etropal AD (XBUL:ETR) » Definitions » YoY EBITDA Growth
Comparable Companies
ATH:PREMIA ATH:PAP ATH:ANDRO ATH:QUEST ATH:ELHA ATH:INTRK ATH:PETRO ATH:KRI ATH:ORILINA ATH:VIDAVO ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST XSWX:STMN
Traded in Other Exchanges
N/A
Address
191 Rusky Boulevard, Etropole, Sofia, BGR, 2180
Website
http://www.etropal.eu
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.